Literature DB >> 29868890

Current Concepts in Diagnosis and Treatment of Functional Neurological Disorders.

Alberto J Espay1, Selma Aybek2, Alan Carson3, Mark J Edwards4, Laura H Goldstein5, Mark Hallett6, Kathrin LaFaver7, W Curt LaFrance8,9, Anthony E Lang10, Tim Nicholson11, Glenn Nielsen4, Markus Reuber12, Valerie Voon13, Jon Stone14, Francesca Morgante4,15.   

Abstract

Importance: Functional neurological disorders (FND) are common sources of disability in medicine. Patients have often been misdiagnosed, correctly diagnosed after lengthy delays, and/or subjected to poorly delivered diagnoses that prevent diagnostic understanding and lead to inappropriate treatments, iatrogenic harm, unnecessary and costly evaluations, and poor outcomes. Observations: Functional Neurological Symptom Disorder/Conversion Disorder was adopted by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, replacing the term psychogenic with functional and removing the criterion of psychological stress as a prerequisite for FND. A diagnosis can now be made in an inclusionary manner by identifying neurological signs that are specific to FNDs without reliance on presence or absence of psychological stressors or suggestive historical clues. The new model highlights a wider range of past sensitizing events, such as physical trauma, medical illness, or physiological/psychophysiological events. In this model, strong ideas and expectations about these events correlate with abnormal predictions of sensory data and body-focused attention. Neurobiological abnormalities include hypoactivation of the supplementary motor area and relative disconnection with areas that select or inhibit movements and are associated with a sense of agency. Promising evidence has accumulated for the benefit of specific physical rehabilitation and psychological interventions alone or in combination, but clinical trial evidence remains limited. Conclusions and Relevance: Functional neurological disorders are a neglected but potentially reversible source of disability. Further research is needed to determine the dose and duration of various interventions, the value of combination treatments and multidisciplinary therapy, and the therapeutic modality best suited for each patient.

Entities:  

Mesh:

Year:  2018        PMID: 29868890      PMCID: PMC7293766          DOI: 10.1001/jamaneurol.2018.1264

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  71 in total

1.  Clinical characteristics of patients with motor disability due to conversion disorder: a prospective control group study.

Authors:  M Binzer; P M Andersen; G Kullgren
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

Review 2.  The role of physical injury in motor and sensory conversion symptoms: a systematic and narrative review.

Authors:  Jon Stone; Alan Carson; Hosakere Aditya; Robin Prescott; Mohammad Zaubi; Charles Warlow; Michael Sharpe
Journal:  J Psychosom Res       Date:  2008-12-17       Impact factor: 3.006

Review 3.  The prognosis of functional (psychogenic) motor symptoms: a systematic review.

Authors:  Jeannette Gelauff; Jon Stone; Mark Edwards; Alan Carson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-09-12       Impact factor: 10.154

4.  Gait abnormalities in psychogenic movement disorders.

Authors:  Jong Sam Baik; Anthony E Lang
Journal:  Mov Disord       Date:  2007-02-15       Impact factor: 10.338

5.  Can semiology predict psychogenic nonepileptic seizures? A prospective study.

Authors:  Tanvir U Syed; W Curt LaFrance; Emine S Kahriman; Saba N Hasan; Vijayalakshmi Rajasekaran; Deepak Gulati; Samip Borad; Asim Shahid; Guadalupe Fernandez-Baca; Naiara Garcia; Matthias Pawlowski; Tobias Loddenkemper; Shahram Amina; Mohamad Z Koubeissi
Journal:  Ann Neurol       Date:  2011-03-17       Impact factor: 10.422

Review 6.  Systematic review of misdiagnosis of conversion symptoms and "hysteria".

Authors:  Jon Stone; Roger Smyth; Alan Carson; Steff Lewis; Robin Prescott; Charles Warlow; Michael Sharpe
Journal:  BMJ       Date:  2005-10-13

7.  Which patients with epilepsy are at risk for psychogenic nonepileptic seizures (PNES)? A multicenter case-control study.

Authors:  Benjamin D Wissel; Alok K Dwivedi; Tyler E Gaston; Federico J Rodriguez-Porcel; Danah Aljaafari; Jennifer L Hopp; Allan Krumholz; Sandra M A van der Salm; Danielle M Andrade; Felippe Borlot; Brian D Moseley; Jennifer L Cavitt; Stevie Williams; Jon Stone; W Curt LaFrance; Jerzy P Szaflarski; Alberto J Espay
Journal:  Epilepsy Behav       Date:  2016-06-27       Impact factor: 2.937

8.  Physiotherapy for functional motor disorders: a consensus recommendation.

Authors:  Glenn Nielsen; Jon Stone; Audrey Matthews; Melanie Brown; Chris Sparkes; Ross Farmer; Lindsay Masterton; Linsey Duncan; Alisa Winters; Laura Daniell; Carrie Lumsden; Alan Carson; Anthony S David; Mark Edwards
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-11-28       Impact factor: 10.154

9.  Impaired emotion processing in functional (psychogenic) tremor: A functional magnetic resonance imaging study.

Authors:  Alberto J Espay; Thomas Maloney; Jennifer Vannest; Matthew M Norris; James C Eliassen; Erin Neefus; Jane B Allendorfer; Anthony E Lang; Jerzy P Szaflarski
Journal:  Neuroimage Clin       Date:  2017-10-18       Impact factor: 4.881

Review 10.  Cranial functional (psychogenic) movement disorders.

Authors:  Diego Kaski; Adolfo M Bronstein; Mark J Edwards; Jon Stone
Journal:  Lancet Neurol       Date:  2015-12       Impact factor: 44.182

View more
  86 in total

Review 1.  A practical review of functional neurological disorder (FND) for the general physician.

Authors:  Karina Bennett; Clare Diamond; Ingrid Hoeritzauer; Paula Gardiner; Laura McWhirter; Alan Carson; Jon Stone
Journal:  Clin Med (Lond)       Date:  2021-01       Impact factor: 2.659

2.  Medico-legal aspects of functional neurological disorders: time for an interdisciplinary dialogue.

Authors:  Michela Colombari; Ilaria A Di Vico; Stefania Turrina; Domenico De Leo; Michele Tinazzi
Journal:  Neurol Sci       Date:  2021-04-03       Impact factor: 3.307

3.  What the Tech? The Management of Neurological Dysfunction Through the Use of Digital Technology.

Authors:  Caitlin Carswell; Paul M Rea
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Corticolimbic fast-tracking: enhanced multimodal integration in functional neurological disorder.

Authors:  Jorge Sepulcre; David L Perez; Ibai Diez; Laura Ortiz-Terán; Benjamin Williams; Rozita Jalilianhasanpour; Juan Pablo Ospina; Bradford C Dickerson; Matcheri S Keshavan; W Curt LaFrance
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-03-08       Impact factor: 10.154

5.  [Functional neurological disorders: update and example of integrated inpatient treatment including mirror therapy].

Authors:  A Joos; R Halmer; N Leiprecht; K Schörner; C Lahmann; C Blahak
Journal:  Nervenarzt       Date:  2020-03       Impact factor: 1.214

6.  Integrated Therapy for Functional Movement Disorders: Time for a Change.

Authors:  Sarah C Lidstone; Lindsey MacGillivray; Anthony E Lang
Journal:  Mov Disord Clin Pract       Date:  2020-01-11

Review 7.  The role of the anterior and midcingulate cortex in the neurobiology of functional neurologic disorder.

Authors:  Juan Pablo Ospina; Rozita Jalilianhasanpour; David L Perez
Journal:  Handb Clin Neurol       Date:  2019

8.  Gender as a Risk Factor for Functional Movement Disorders: The Role of Sexual Abuse.

Authors:  Isaiah Kletenik; Stefan H Sillau; Sanaz Attaripour Isfahani; Kathrin LaFaver; Mark Hallett; Brian D Berman
Journal:  Mov Disord Clin Pract       Date:  2019-12-13

9.  Voluntary Inhibitory Control of Chorea: A Case Series.

Authors:  Roberta Bonomo; Anna Latorre; Bettina Balint; Katarzyna Smilowska; Lorenzo Rocchi; John C Rothwell; Mario Zappia; Kailash P Bhatia
Journal:  Mov Disord Clin Pract       Date:  2020-02-20

10.  Hiding in Plain Sight: Functional Neurological Disorders in the News.

Authors:  Stoyan Popkirov; Timothy R Nicholson; Bastiaan R Bloem; Hannah R Cock; Christopher P Derry; Roderick Duncan; Barbara A Dworetzky; Mark J Edwards; Alberto J Espay; Mark Hallett; Anthony E Lang; John Paul Leach; Alexander Lehn; Aileen McGonigal; Francesca Morgante; David L Perez; Markus Reuber; Mark P Richardson; Philip Smith; Maria Stamelou; Marina A J Tijssen; Michele Tinazzi; Alan J Carson; Jon Stone
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2019-05-23       Impact factor: 2.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.